Immunomodulation of neutrophils and platelets by TNF blockage in patients with juvenile idiopathic arthritis
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
36336331
DOI
10.1016/j.clim.2022.109170
PII: S1521-6616(22)00251-0
Knihovny.cz E-zdroje
- Klíčová slova
- Juvenile idiopathic arthritis, MMP8, Neutrophil, Neutrophil-platelet aggregates, Platelet, S100, TNF inhibitors,
- MeSH
- aktivace neutrofilů MeSH
- imunomodulace MeSH
- juvenilní artritida * MeSH
- lidé MeSH
- neutrofily MeSH
- trombocyty MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Juvenile idiopathic arthritis (JIA) is a multifactorial autoimmune disease mediated by both adaptive and innate immunity. The role of neutrophils in the pathogenesis of autoimmune diseases is well-established; however, in JIA they are still markedly understudied. Here, we explored the neutrophil features and role of platelet-neutrophil aggregates in JIA patients and assessed the effect of TNF inhibitor (TNFi) therapy. We provide evidence of dysbalanced neutrophil subsets in JIA patients, with a shift towards immature and suppressive subpopulations that lack the cell-adhesion molecules. Correspondingly, patient sera contained high amounts of neutrophil- and platelet-related products. Transcriptomic analysis revealed neutrophil degranulation as the most affected process by TNFi therapy, which was mirrored by the decrease in degranulation products in the patient sera. Toll-like receptors -4, -7, and - 8 signaling pathways are particularly hyperresponsive in patients, but are strongly suppressed by TNFi. Overall, our study demonstrates augmented neutrophil and platelet responses in JIA patients.
Citace poskytuje Crossref.org